Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo threevessel disease

  1. Escaned, J.
  2. Banning, A.
  3. Farooq, V.
  4. Echavarria-Pinto, M.
  5. Onuma, Y.
  6. Ryan, N.
  7. Cavalcante, R.
  8. Campos, C.M.
  9. Stanetic, B.M.
  10. Ishibashi, Y.
  11. Suwannasom, P.
  12. Kappetein, A.-P.
  13. Taggart, D.
  14. Morel, M.-A.
  15. Es, G.-A.V.
  16. Serruys, P.W.
Revue:
EuroIntervention

ISSN: 1969-6213,  1774-024X

Année de publication: 2016

Volumen: 12

Número: 2

Pages: e224-e234

Type: Article

DOI: 10.4244/EIJV12I2A36 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus